217 related articles for article (PubMed ID: 28095746)
1. Targeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapy.
Gupta A; Kaur CD; Saraf S; Saraf S
J Recept Signal Transduct Res; 2017 Jun; 37(3):314-323. PubMed ID: 28095746
[TBL] [Abstract][Full Text] [Related]
2. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
3. Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells.
Pinhassi RI; Assaraf YG; Farber S; Stark M; Ickowicz D; Drori S; Domb AJ; Livney YD
Biomacromolecules; 2010 Jan; 11(1):294-303. PubMed ID: 20014825
[TBL] [Abstract][Full Text] [Related]
4. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
Low PS; Henne WA; Doorneweerd DD
Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
[TBL] [Abstract][Full Text] [Related]
5. A Novel Folate-Targeted Nanoliposomal System of Doxorubicin for Cancer Targeting.
Lohade AA; Jain RR; Iyer K; Roy SK; Shimpi HH; Pawar Y; Rajan MG; Menon MD
AAPS PharmSciTech; 2016 Dec; 17(6):1298-1311. PubMed ID: 26689406
[TBL] [Abstract][Full Text] [Related]
6. [Folate receptor and its application in the selective receptor-mediated targeting therapy of tumor cells--review].
Gao XN; Tang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):911-4. PubMed ID: 16277870
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
Hilgenbrink AR; Low PS
J Pharm Sci; 2005 Oct; 94(10):2135-46. PubMed ID: 16136558
[TBL] [Abstract][Full Text] [Related]
8. Folate-mediated targeting of therapeutic and imaging agents to cancers.
Reddy JA; Low PS
Crit Rev Ther Drug Carrier Syst; 1998; 15(6):587-627. PubMed ID: 9883391
[TBL] [Abstract][Full Text] [Related]
9. Folate-targeted chemotherapy.
Leamon CP; Reddy JA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831
[TBL] [Abstract][Full Text] [Related]
11. Folate-conjugated nanovehicles: Strategies for cancer therapy.
Farran B; Montenegro RC; Kasa P; Pavitra E; Huh YS; Han YK; Kamal MA; Nagaraju GP; Rama Raju GS
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110341. PubMed ID: 31761235
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry.
Carron PM; Crowley A; O'Shea D; McCann M; Howe O; Hunt M; Devereux M
Curr Med Chem; 2018; 25(23):2675-2708. PubMed ID: 29424300
[TBL] [Abstract][Full Text] [Related]
13. To Conjugate or to Package? A Look at Targeted siRNA Delivery Through Folate Receptors.
Salim L; Desaulniers JP
Nucleic Acid Ther; 2021 Feb; 31(1):21-38. PubMed ID: 33121373
[TBL] [Abstract][Full Text] [Related]
14. An outlook on procedures of conjugating folate to (co)polymers and drugs for effective cancer targeting.
Kharkar PS; Soni G; Rathod V; Shetty S; Gupta MK; Yadav KS
Drug Dev Res; 2020 Nov; 81(7):823-836. PubMed ID: 32515120
[TBL] [Abstract][Full Text] [Related]
15. Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.
Vergote IB; Marth C; Coleman RL
Cancer Metastasis Rev; 2015 Mar; 34(1):41-52. PubMed ID: 25564455
[TBL] [Abstract][Full Text] [Related]
16. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures.
Luong D; Kesharwani P; Killinger BA; Moszczynska A; Sarkar FH; Padhye S; Rishi AK; Iyer AK
J Colloid Interface Sci; 2016 Dec; 484():33-43. PubMed ID: 27585998
[TBL] [Abstract][Full Text] [Related]
17. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
18. [Folate receptor-mediated antitumor drugs].
Zhao J; Cao SL; Zheng XL; Zhao B
Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
[TBL] [Abstract][Full Text] [Related]
19. Effect of receptor occupancy on folate receptor internalization.
Bandara NA; Hansen MJ; Low PS
Mol Pharm; 2014 Mar; 11(3):1007-13. PubMed ID: 24446917
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy.
Guaragna A; Chiaviello A; Paolella C; D'Alonzo D; Palumbo G; Palumbo G
Bioconjug Chem; 2012 Jan; 23(1):84-96. PubMed ID: 22121907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
